Oxetanes as Versatile Elements in Drug Discovery and Synthesis

Authors

  • Johannes A. Burkhard,

    1. Laboratorium für Organische Chemie, ETH Zürich, HCI H335, 8093 Zürich (Switzerland), Fax: (+41) 44-632-1328
    Search for more papers by this author
  • Dr. Georg Wuitschik,

    1. Laboratorium für Organische Chemie, ETH Zürich, HCI H335, 8093 Zürich (Switzerland), Fax: (+41) 44-632-1328
    Search for more papers by this author
  • Dr. Mark Rogers-Evans,

    Corresponding author
    1. F. Hoffmann–La Roche AG, Pharmaceuticals Division, 4070 Basel (Switzerland), Fax: (+41) 61-688-6965
    • F. Hoffmann–La Roche AG, Pharmaceuticals Division, 4070 Basel (Switzerland), Fax: (+41) 61-688-6965
    Search for more papers by this author
  • Prof. Dr. Klaus Müller,

    Corresponding author
    1. F. Hoffmann–La Roche AG, Pharmaceuticals Division, 4070 Basel (Switzerland), Fax: (+41) 61-688-6965
    • F. Hoffmann–La Roche AG, Pharmaceuticals Division, 4070 Basel (Switzerland), Fax: (+41) 61-688-6965
    Search for more papers by this author
  • Prof. Dr. Erick M. Carreira

    Corresponding author
    1. Laboratorium für Organische Chemie, ETH Zürich, HCI H335, 8093 Zürich (Switzerland), Fax: (+41) 44-632-1328
    • Laboratorium für Organische Chemie, ETH Zürich, HCI H335, 8093 Zürich (Switzerland), Fax: (+41) 44-632-1328
    Search for more papers by this author

Abstract

Sizable resources, both financial and human, are invested each year in the development of new pharmaceutical agents. However, despite improved techniques, the new compounds often encounter difficulties in satisfying and overcoming the numerous physicochemical and many pharmacological constraints and hurdles. Oxetanes have been shown to improve key properties when grafted onto molecular scaffolds. Of particular interest are oxetanes that are substituted only in the 3-position, since such units remain achiral and their introduction into a molecular scaffold does not create a new stereocenter. This Minireview gives an overview of the recent advances made in the preparation and use of 3-substituted oxetanes. It also includes a discussion of the site-dependent modifications of various physicochemical and biochemical properties that result from the incorporation of the oxetane unit in molecular architectures.

Ancillary